Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Dalrada Technology Group ( (DHTI) ) has issued an update.
On April 24, 2026, Dalrada Technology Group, Inc. and certain subsidiaries received a notice of default from Nautilus Parent Holdings, LLC and Nautilus Funding Solutions, LLC – Series XIII, citing missed payments under a series of term loan and loan-and-security agreements dating back to July 25, 2023. The lenders demanded a $500,000 cure payment by May 1, 2026, warned they may accelerate the loan balances and initiate enforcement actions if payment is not made, and Dalrada said it is reviewing the notice and plans to discuss a resolution, while acknowledging there is no assurance the defaults will be cured or enforcement avoided.
Spark’s Take on DHTI Stock
According to Spark, TipRanks’ AI Analyst, DHTI is a Neutral.
Dalrada Financial’s overall performance is hindered by significant financial challenges, including negative earnings and high leverage. While there are some positive short-term technical indicators, the overbought conditions suggest potential volatility. The valuation remains unattractive, primarily due to negative profitability metrics.
To see Spark’s full report on DHTI stock, click here.
More about Dalrada Technology Group
Dalrada Technology Group, Inc. is a diversified technology company whose operations include subsidiaries such as Genefic Specialty RX, Inc. and Genefic, Inc., indicating exposure to healthcare or specialty pharmacy financing. The group utilizes term loans and factoring arrangements to fund its activities, reflecting a reliance on structured debt facilities to support its growth and working capital needs.
Average Trading Volume: 15,998
Technical Sentiment Signal: Sell
Current Market Cap: $4.93M
Find detailed analytics on DHTI stock on TipRanks’ Stock Analysis page.